|
1
|
Morishita A and Masaki T: miRNA in
hepatocellular carcinoma. Hepatol Res. 45:128–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15 Suppl
4:S5–S13. 2010. View Article : Google Scholar
|
|
3
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han ZG: Functional genomic studies:
Insights into the pathogenesis of liver cancer. Annu Rev Genomics
Hum Genet. 13:171–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meyerson M, Gabriel S and Getz G: Advances
in understanding cancer genomes through second-generation
sequencing. Nat Rev Genet. 11:685–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shendure J and Ji H: Next-generation DNA
sequencing. Nat Biotechnol. 26:1135–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mardis ER, Ding L, Dooling DJ, Larson DE,
McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath
SD, et al: Recurring mutations found by sequencing an acute myeloid
leukemia genome. N Engl J Med. 361:1058–1066. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pleasance ED, Stephens PJ, O'Meara S,
McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman
C, et al: A small-cell lung cancer genome with complex signatures
of tobacco exposure. Nature. 463:184–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berger MF, Hodis E, Heffernan TP, Deribe
YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E,
Ghosh P, et al: Melanoma genome sequencing reveals frequent PREX2
mutations. Nature. 485:502–506. 2012.PubMed/NCBI
|
|
12
|
Nikolaev SI, Rimoldi D, Iseli C, Valsesia
A, Robyr D, Gehrig C, Harshman K, Guipponi M, Bukach O, Zoete V, et
al: Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2
mutations in melanoma. Nat Genet. 44:133–139. 2012. View Article : Google Scholar
|
|
13
|
Prickett TD, Wei X, Cardenas-Navia I, Teer
JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A,
et al: Exon capture analysis of G protein-coupled receptors
identifies activating mutations in GRM3 in melanoma. Nat Genet.
43:1119–1126. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stark MS, Woods SL, Gartside MG, Bonazzi
VF, Dutton-Regester K, Aoude LG, Chow D, Sereduk C, Niemi NM, Tang
N, et al: Frequent somatic mutations in MAP3K5 and MAP3K9 in
metastatic melanoma identified by exome sequencing. Nat Genet.
44:165–169. 2012. View
Article : Google Scholar
|
|
15
|
Wei X, Walia V, Lin JC, Teer JK, Prickett
TD, Gartner J, Davis S; NISC Comparative Sequencing Program, ;
Stemke-Hale K, Davies MA, et al: Exome sequencing identifies GRIN2A
as frequently mutated in melanoma. Nat Genet. 43:442–446. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Puente XS, Pinyol M, Quesada V, Conde L,
Ordóñez GR, Villamor N, Escaramis G, Jares P, Beà S, González-Díaz
M, et al: Whole-genome sequencing identifies recurrent mutations in
chronic lymphocytic leukaemia. Nature. 475:101–105. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papaemmanuil E, Cazzola M, Boultwood J,
Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS,
Hellstrom-Lindberg E, Gambacorti-Passerini C, et al: Somatic SF3B1
mutation in myelodysplasia with ring sideroblasts. N Engl J Med.
365:1384–1395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshida K, Sanada M, Shiraishi Y, Nowak D,
Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, et
al: Frequent pathway mutations of splicing machinery in
myelodysplasia. Nature. 478:64–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang K, Kan J, Yuen ST, Shi ST, Chu KM,
Law S, Chan TL, Kan Z, Chan AS, Tsui WY, et al: Exome sequencing
identifies frequent mutation of ARID1A in molecular subtypes of
gastric cancer. Nat Genet. 43:1219–1223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y,
Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et
al: ARID1A mutations in endometriosis-associated ovarian
carcinomas. N Engl J Med. 363:1532–1543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thorvaldsdottir H, Robinson JT and Mesirov
JP: Integrative Genomics Viewer (IGV): High-performance genomics
data visualization and exploration. Brief Bioinform. 14:178–192.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Greenman C, Stephens P, Smith R, Dalgliesh
GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C,
et al: Patterns of somatic mutation in human cancer genomes.
Nature. 446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guichard C, Amaddeo G, Imbeaud S, Ladeiro
Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M,
Degos F, et al: Integrated analysis of somatic mutations and focal
copy-number changes identifies key genes and pathways in
hepatocellular carcinoma. Nat Genet. 44:694–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li M, Zhao H, Zhang X, Wood LD, Anders RA,
Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, et al:
Inactivating mutations of the chromatin remodeling gene ARID2 in
hepatocellular carcinoma. Nat Genet. 43:828–829. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujimoto A, Totoki Y, Abe T, Boroevich KA,
Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al:
Whole-genome sequencing of liver cancers identifies etiological
influences on mutation patterns and recurrent mutations in
chromatin regulators. Nat Genet. 44:760–764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang Z, Jhunjhunwala S, Liu J, Haverty
PM, Kennemer MI, Guan Y, Lee W, Carnevali P, Stinson J, Johnson S,
et al: The effects of hepatitis B virus integration into the
genomes of hepatocellular carcinoma patients. Genome Res.
22:593–601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Totoki Y, Tatsuno K, Yamamoto S, Arai Y,
Hosoda F, Ishikawa S, Tsutsumi S, Sonoda K, Totsuka H, Shirakihara
T, et al: High-resolution characterization of a hepatocellular
carcinoma genome. Nat Genet. 43:464–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim CJ, Cho YG, Park JY, Kim TY, Lee JH,
Kim HS, Lee JW, Song YH, Nam SW, Lee SH, et al: Genetic analysis of
the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer.
40:136–141. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang YH, Chen ZK, Huang KT, Li P, He B,
Guo X, Zhong JQ, Zhang QY, Shi HQ, Song QT, et al: Decreased
expression of LKB1 correlates with poor prognosis in hepatocellular
carcinoma patients undergoing hepatectomy. Asian Pac J Cancer Prev.
14:1985–1988. 2013. View Article : Google Scholar : PubMed/NCBI
|
